Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) said its revenue for the first quarter ended January 31, 2023, rose by 210% to a record $13.2 million, up from $4.2.
Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) has reported record financial results for the fourth quarter and fiscal 2022 as it expanded its product portfolio.
Valeo Pharma Reports Record Quarterly and Annual Revenues for the Fourth Quarter and the Fiscal Year 2022 investorintel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorintel.com Daily Mail and Mail on Sunday newspapers.
ChitogenX Inc pursues sales of chitosan as a new revenue initiative in fiscal 3Q and restructures balance sheet proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.